European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1309-1315, December 2008

Outcome of R1 resection in patients undergoing pancreatico-duodenectomy for pancreatic cancer

  • G. Fusai

      Affiliations

    • University Department of Surgery and Liver Transplant Unit, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, NW3 2QG London, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 7940500x31316; fax: +44 207 8302688.
  • ,
  • N. Warnaar

      Affiliations

    • University Department of Surgery and Liver Transplant Unit, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, NW3 2QG London, United Kingdom
  • ,
  • C.A. Sabin

      Affiliations

    • Department of Primary Care & Population Sciences, Royal Free & University College Medical School, Rowland Hill Street, NW3 2PF London, United Kingdom
  • ,
  • S. Archibong

      Affiliations

    • University Department of Surgery and Liver Transplant Unit, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, NW3 2QG London, United Kingdom
  • ,
  • B.R. Davidson

      Affiliations

    • University Department of Surgery and Liver Transplant Unit, Royal Free Hospital, Royal Free and University College Medical School, Pond Street, NW3 2QG London, United Kingdom

Accepted 16 January 2008.

Abstract 

Background

Pancreatico-duodenectomy (PD) is the only potentially curative treatment for pancreatic cancer, but most surgeons are reluctant to perform a palliative resection. The aim was to define the outcome for microscopically incomplete PD (R1).

Methods

Ninety-nine consecutive patients underwent laparotomy to perform PD. Sixty-seven patients were resected and 32 underwent palliative bypass (PSB) because of locally advanced disease.

Results

Of the 67 PD, 27 were classified as R0 and 40 as R1. Median survival for R0, R1 and PSB were 24, 18 and 9 months, respectively. Survival in the PSB group was 34% at 1 year and 0% at 2 years. 1-, 2- and 5-year survival in the R0 and R1 groups was 79% and 70%, 48.3% and 39.1%, 21.5% and 9.9%, respectively. Compared to PSB, both other groups were less likely to die over follow-up (p=0.002). Survival was not significantly different between the R0 and R1 groups (p=0.21). Perioperative morbidity and mortality were similar in the PD and PSB groups (29.9% and 3.0% vs 31.3 and 3.1%, respectively, p=1.00).

Conclusions

Better survival in the resection group and similar perioperative risk would support the decision to perform PD even when there is the possibility of incomplete microscopic clearance.

Keywords: Pancreatic resection, Positive margin, Periampullary tumour, Non-radical, Residual disease

Abbreviations: PD, pancreatico-duodenectomy, PSB, palliative surgical bypass, GED, delayed gastric emptying

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(08)00033-4

doi:10.1016/j.ejso.2008.01.017

European Journal of Surgical Oncology
Volume 34, Issue 12 , Pages 1309-1315, December 2008